Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
$40.19
+0.0%
$4.11
$0.28
$17.38
$1.27B3.65373,201 shs208 shs
JAND
Innovator Premium Income 10 Barrier ETF - January
$24.64
$24.64
$24.24
$25.38
$4.93M0.246,070 shs2,087 shs
LAPR
Innovator Premium Income 15 Buffer ETF - April
$25.14
0.0%
$25.07
$24.06
$25.21
$7.04M0.221,884 shs16 shs
XDOC
Innovator U.S. Equity Accelerated ETF - October
$32.45
+0.4%
$31.39
$25.08
$32.66
$3.24M0.811,405 shs2,878 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
+0.05%+0.54%+4.22%+12.46%+882.15%
JAND
Innovator Premium Income 10 Barrier ETF - January
0.00%0.00%0.00%0.00%-1.36%
LAPR
Innovator Premium Income 15 Buffer ETF - April
-0.04%+0.08%+0.40%+2.53%-0.04%
XDOC
Innovator U.S. Equity Accelerated ETF - October
-0.05%+0.40%+4.20%+17.86%+11.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
JAND
Innovator Premium Income 10 Barrier ETF - January
N/AN/AN/AN/AN/AN/AN/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
N/AN/AN/AN/AN/AN/AN/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
0.00
N/AN/AN/A
JAND
Innovator Premium Income 10 Barrier ETF - January
0.00
N/AN/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
0.00
N/AN/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/A$0.95 per shareN/A
JAND
Innovator Premium Income 10 Barrier ETF - January
N/AN/AN/AN/AN/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
N/AN/AN/AN/AN/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
-$40.86MN/A0.00N/AN/A-81.29%-56.92%N/A
JAND
Innovator Premium Income 10 Barrier ETF - January
N/AN/A0.00N/AN/AN/AN/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
N/AN/A0.00N/AN/AN/AN/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
N/AN/A24.75N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/AN/A
JAND
Innovator Premium Income 10 Barrier ETF - January
$1.967.95%N/AN/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
$1.395.53%N/AN/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/A31.51 millionN/ANot Optionable
JAND
Innovator Premium Income 10 Barrier ETF - January
N/A200,000N/AN/A
LAPR
Innovator Premium Income 15 Buffer ETF - April
N/A280,000N/AN/A
XDOC
Innovator U.S. Equity Accelerated ETF - October
N/A100,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Top Headlines

View All Headlines
Edge Therapeutics stock logo

Edge Therapeutics NASDAQ:EDGE

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

Innovator Premium Income 10 Barrier ETF - January NYSEARCA:JAND

$24.64 0.00 (0.00%)
As of 01/2/2025

The Innovator Premium Income 10 Barrier ETF - January (JAND) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide a consistent income stream and a limited protective barrier against losses over a one-year period. The actively managed fund holds a package of S&P 500 FLEX options and US Treasurys. JAND was launched on Dec 31, 2023 and is issued by Innovator.

Innovator Premium Income 15 Buffer ETF - April NYSEARCA:LAPR

$25.14 -0.01 (-0.04%)
As of 07/15/2025 04:10 PM Eastern

The Innovator Premium Income 15 Buffer ETF — April (LAPR) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund seeks to provide a consistent income stream and a limited protective buffer against the first 15% of SPDR S&P 500 ETF Trust (SPY) losses. The exposure resets each year in April LAPR was launched on Apr 1, 2024 and is issued by Innovator.

Innovator U.S. Equity Accelerated ETF - October BATS:XDOC

$32.45 +0.13 (+0.39%)
As of 11:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Innovator U.S. Equity Accelerated ETF - October (XDOC) is an exchange-traded fund that is based on the SPDR S&P 500 ETF Trust index. The fund aims for 2x the price return of the SPDR S&P 500 ETF (SPY), subject to an upside return cap over a one-year outcome period. XDOC was launched on Oct 1, 2021 and is managed by Innovator.